What’s Important for Success of Multi-Sector Consortium in Regenerative Medicine
Recently, Japan has given two prominent topics, bad and good, to the global regenerative medicine community. The former is the over-promoted but fabricated STAP stem cell papers, and the latter is a rather unusual bold move by Japanese government to start flexible and relaxed regulation to advance the stem cell-based therapy. Then, what are happening in Japan?
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.